Drug Profile
Meningococcal polysaccharide vaccine groups ACYW135 - Beijing Tiantan Biological
Alternative Names: Meningococcal ACWY Vaccine; Meningococcal vaccine groups A, C, W135 and Y polysaccharideLatest Information Update: 28 Mar 2018
Price :
$50
*
At a glance
- Originator Beijing Tiantan Biological Products Company
- Developer Beijing Center for Disease Control and Prevention; Beijing Tiantan Biological Products Company
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase III Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
Most Recent Events
- 28 Mar 2018 No recent reports of development identified for preclinical development in Meningococcal-group-A-infections in China (IM)
- 28 Mar 2018 No recent reports of development identified for preclinical development in Meningococcal-group-C-infections in China (IM)
- 28 Mar 2018 No recent reports of development identified for preclinical development in Meningococcal-group-W-135-infections in China (IM)